Black Diamond Therapeutics (NASDAQ:BDTX) Given New $15.00 Price Target at Stifel Nicolaus
Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) had its target price decreased by Stifel Nicolaus from $16.00 to $15.00 in a research report released on Friday morning,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Separately, Wedbush reiterated an “outperform” rating and set a $11.00 price target (down previously from $16.00) on […]
Black Diamond Therapeutics (NASDAQ:BDTX – Free Report) had its target price decreased by Stifel Nicolaus from $16.00 to $15.00 in a research report released on Friday morning,Benzinga reports. Stifel Nicolaus currently has a buy rating on the stock. Separately, Wedbush reiterated an “outperform” rating and set a $11.00 price target (down previously from $16.00) on […]
